B
Berend R. Beumer
Researcher at Erasmus University Rotterdam
Publications - 16
Citations - 996
Berend R. Beumer is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 10 publications receiving 691 citations.
Papers
More filters
Journal ArticleDOI
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
Mustafa Suker,Berend R. Beumer,Eran Sadot,Lysiane Marthey,Jason E. Faris,Eric A. Mellon,Bassel F. El-Rayes,Andrea Wang-Gillam,Jill Lacy,Peter J. Hosein,Sing Yu Moorcraft,Thierry Conroy,Florian Hohla,Peter J. Allen,Julien Taieb,Theodore S. Hong,Ravi Shridhar,Ian Chau,Casper H.J. van Eijck,Bas Groot Koerkamp +19 more
TL;DR: Patients with locally advanced pancreatic cancer treated with FOLFIRINOX had a median overall survival of 24·2 months-longer than that reported with gemcitabine (6-13 months).
Journal ArticleDOI
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
Quisette P. Janssen,Stefan Buettner,Mustafa Suker,Berend R. Beumer,Pietro Addeo,Philippe Bachellier,Nathan Bahary,Tanios Bekaii-Saab,Maria Antonietta Bali,Marc G. Besselink,Brian A. Boone,Ian Chau,Stephen Clarke,Mary Dillhoff,Bassel F. El-Rayes,Jessica M. Frakes,Derek Grose,Peter J. Hosein,Nigel B. Jamieson,Ammar A. Javed,Khurum Khan,Kyu Pyo Kim,Song Cheol Kim,Sunhee S. Kim,Andrew H. Ko,Jill Lacy,Georgios A. Margonis,Martin D. McCarter,Colin J. McKay,Eric A. Mellon,Sing Yu Moorcraft,Ken Ichi Okada,Alessandro Paniccia,Parag J. Parikh,Niek A. Peters,Hans Rabl,Jaswinder S. Samra,Christoph Tinchon,Geertjan van Tienhoven,Eran van Veldhuisen,Andrea Wang-Gillam,Matthew J. Weiss,Johanna W. Wilmink,Hiroki Yamaue,Marjolein Y.V. Homs,Casper H.J. van Eijck,Matthew H.G. Katz,Bas Groot Koerkamp +47 more
TL;DR: This patient-level meta-analysis of BRPC patients treated with neoadjuvant FOLFIRINOX showed a favorable median OS, resection rate, and R0-resection rate, which need to be assessed in a randomized trial.
Journal ArticleDOI
Study quality on groin injury management remains low: a systematic review on treatment of groin pain in athletes
Andreas Serner,Casper H.J. van Eijck,Berend R. Beumer,Per Hölmich,Adam Weir,Robert-Jan de Vos +5 more
TL;DR: There is moderate evidence for the efficacy of conservative treatment (active exercises and multimodal treatments) and for surgery in patients with adductor-related groin pain and for efficacy of surgical treatment in sportsman's hernia.
Journal ArticleDOI
Quality and performance of validated prognostic models for survival after resection of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
Stefan Büttner,Boris Galjart,Berend R. Beumer,Jeroen L.A. van Vugt,Casper H.J. van Eijck,Wojciech G. Polak,Jeroen de Jonge,Marjolein Y.V. Homs,Lydi M.J.W. van Driel,Timothy M. Pawlik,Ewout W. Steyerberg,Jan N. M. IJzermans,Bas Groot Koerkamp +12 more
TL;DR: The Wang model for prognosis after resection of i CCA has good quality and good performance at external validation, while most prognostic models for iCCA have been developed with poor methodological quality and show poor performance at internal validation.
Journal ArticleDOI
A patient-level meta-analysis of FOLFIRINOX for locally advanced pancreatic cancer.
Mustafa Suker,Berend R. Beumer,Eran Sadot,Lysiane Marthey,Jason E. Faris,Eric A. Mellon,Bassel F. El-Rayes,Andrea Wang-Gillam,Jill Lacy,Peter J. Hosein,Sing Yu Moorcraft,Thierry Conroy,Florian Hohla,Peter J. Allen,Julien Taieb,Theodore S. Hong,Ravi Shridhar,Ian Chau,Casper H.J. van Eijck,Bas Groot Koerkamp +19 more